| Name | Title | Contact Details |
|---|
Our technology has been tested by top institutions and is used in hundreds of facilities throughout the world. We developed a technology that significantly reduces unhealthy contaminants. This technology quickly and effectively decreases airborne viruses, bacteria, particulates, mold, VOCs and odors. It cleans the air and creates a healthier environment.
Nucon International Inc is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Opya, Inc. is changing how autism care is delivered for children newly diagnosed with autism & and transforming the lives of neuro-diverse children & their families. For in-home ABA therapy services in the Bay Area, contact us today!
Medaudit Services Inc is a Midland, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.